Although respiratory failure due to pulmonary edema was recently reported with the use of vasoconstrictors (Wong et al., 2021) and albumin (China et al., 2021), it could not be linked in the current study to the use of any of the studied medications due to the small number of patients that suffered from this adverse event. This evidence concerns the gene ALB and pulmonary edema.